Samsung Acquires NeuroLogica

By Admin
Follow @HealthCareG Samsung plans expansion into the medical device sector Computer giant acquires NeuroLogica as part of its expansion Samsung has...

Samsung has announced its acquisition of medical imaging company NeuroLogica. The technology giant plans to build a leading medical technology business and “the acquisition of NeuroLogica is another important step in the expansion of Samsung’s medical imaging business,” said Tod Pike, Senior VP at Samsung’s Enterprise Division.

The press statement outlines Samsung’s plans to expand its medical division, however terms of the deal itself were not disclosed.  

NeuroLogica was founded in 2004 in Boston and it known for its portable computed tomography (CT) scanners, including BodyTom and CereTom.

Samsung has outlined ambitious plans to become one of the world’s leading medical equipment suppliers by 2020.

In November 2012, Samsung Electronics America, a subsidiary of Samsung, announced the addition of Samsung Health & Medical Equipment, which merged employees from Samsung Medison America, its ultrasound machine manufacturer, into its Enterprise Business Division.

Samsung had acquired Medison in 2010 and its medical technology business as a “key element in Samsung’s 2020 vision to explore new areas of growth,” said the company at the time.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare